Literature DB >> 8381057

Uncoupling of human cardiac beta-adrenoceptors during cardiopulmonary bypass with cardioplegic cardiac arrest.

D Schranz1, A Droege, A Broede, G Brodermann, E Schäfer, H Oelert, O E Brodde.   

Abstract

BACKGROUND: It is well known that during cardiopulmonary bypass (CPB) with cardioplegic cardiac arrest, catecholamines are vigorously increased. We therefore investigated whether this might cause desensitization of human cardiac beta-adrenoceptors. METHODS AND
RESULTS: We assessed in 12 children with acyanotic congenital heart disease who underwent open-heart surgery right atrial beta-adrenoceptor number and subtype distribution [by (-)-[125I]iodocyanopindolol binding] and adenylate cyclase activation [by the beta-adrenoceptor agonist isoprenaline (100 microM) and by the non-receptor-mediated activators 10 microM GTP, 10 mM NaF, 100 microM forskolin, and 10 mM Mn2+] before and after CPB with cardiac arrest by means of St. Thomas' cardioplegic solution. CPB affected neither beta-adrenoceptor number of subtype distribution nor GTP-, NaF-, forskolin-, or Mn(2+)-induced activation of adenylate cyclase. In contrast, activation of adenylate cyclase by 100 microM isoprenaline was significantly (p = 0.0249) lower after CPB than before CPB.
CONCLUSIONS: CPB with cardioplegic cardiac arrest decreases beta-adrenoceptor-mediated adenylate cyclase activation in a manner compatible with an uncoupling of beta-adrenoceptors from the Gs-protein-adenylate cyclase complex. Such a beta-adrenoceptor desensitization may be the reason why after CPB many patients need inotropic support but do not respond sufficiently to catecholamines.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8381057     DOI: 10.1161/01.cir.87.2.422

Source DB:  PubMed          Journal:  Circulation        ISSN: 0009-7322            Impact factor:   29.690


  3 in total

1.  Uncoupling of myocardial beta-adrenergic receptor signaling during coronary artery bypass grafting: the role of GRK2.

Authors:  Christian F Bulcao; Prakash K Pandalai; Karen M D'Souza; Walter H Merrill; Shahab A Akhter
Journal:  Ann Thorac Surg       Date:  2008-10       Impact factor: 4.330

Review 2.  "Nihilism" of chronic heart failure therapy in children and why effective therapy is withheld.

Authors:  Dietmar Schranz; Norbert F Voelkel
Journal:  Eur J Pediatr       Date:  2016-02-19       Impact factor: 3.183

3.  In patients chronically treated with metoprolol, the demand of inotropic catecholamine support after coronary artery bypass grafting is determined by the Arg389Gly-beta 1-adrenoceptor polymorphism.

Authors:  Kirsten Leineweber; Petra Bogedain; Christina Wolf; Sören Wagner; Melanie Weber; Heinz-Günther Jakob; Gerd Heusch; Thomas Philipp; Otto-Erich Brodde
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2007-06-01       Impact factor: 3.195

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.